-
1
-
-
79952445042
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the american college of cardiology foundation/american heart association task force on practice guidelines
-
10.1016/j.jacc.2011.01.010, 21324629
-
Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the american college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 2011, 57(11):1330-1337. 10.1016/j.jacc.2011.01.010, 21324629.
-
(2011)
J Am Coll Cardiol
, vol.57
, Issue.11
, pp. 1330-1337
-
-
Wann, L.S.1
Curtis, A.B.2
Ellenbogen, K.A.3
Estes, N.A.4
Ezekowitz, M.D.5
Jackman, W.M.6
January, C.T.7
Lowe, J.E.8
Page, R.L.9
Slotwiner, D.J.10
-
2
-
-
0017900027
-
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study
-
10.1212/WNL.28.10.973, 570666
-
Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978, 28(10):973-977. 10.1212/WNL.28.10.973, 570666.
-
(1978)
Neurology
, vol.28
, Issue.10
, pp. 973-977
-
-
Wolf, P.A.1
Dawber, T.R.2
Thomas, H.E.3
Kannel, W.B.4
-
3
-
-
33846564006
-
Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control
-
Sherman DG. Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control. Stroke 2007, 38(2 Suppl):615-617.
-
(2007)
Stroke
, vol.38
, Issue.2 SUPPL
, pp. 615-617
-
-
Sherman, D.G.1
-
4
-
-
1842434297
-
Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) Study
-
Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, et al. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) Study. Circulation 2004, 109(12):1509-1513.
-
(2004)
Circulation
, vol.109
, Issue.12
, pp. 1509-1513
-
-
Corley, S.D.1
Epstein, A.E.2
DiMarco, J.P.3
Domanski, M.J.4
Geller, N.5
Greene, H.L.6
Josephson, R.A.7
Kellen, J.C.8
Klein, R.C.9
Krahn, A.D.10
-
5
-
-
0037028022
-
A comparison of rate control and rhythm control in patients with atrial fibrillation
-
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002, 347(23):1825-1833.
-
(2002)
N Engl J Med
, vol.347
, Issue.23
, pp. 1825-1833
-
-
Wyse, D.G.1
Waldo, A.L.2
DiMarco, J.P.3
Domanski, M.J.4
Rosenberg, Y.5
Schron, E.B.6
Kellen, J.C.7
Greene, H.L.8
Mickel, M.C.9
Dalquist, J.E.10
-
6
-
-
1042299094
-
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study
-
10.1016/j.jacc.2003.08.037, 14736444
-
Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004, 43(2):241-247. 10.1016/j.jacc.2003.08.037, 14736444.
-
(2004)
J Am Coll Cardiol
, vol.43
, Issue.2
, pp. 241-247
-
-
Hagens, V.E.1
Ranchor, A.V.2
Van Sonderen, E.3
Bosker, H.A.4
Kamp, O.5
Tijssen, J.G.6
Kingma, J.H.7
Crijns, H.J.8
Van Gelder, I.C.9
-
7
-
-
3042782711
-
Randomized trials of rate vs. rhythm control for atrial fibrillation
-
Chung MK. Randomized trials of rate vs. rhythm control for atrial fibrillation. J Interv Card Electrophysiol 2004, 10(Suppl 1):45-53.
-
(2004)
J Interv Card Electrophysiol
, vol.10
, Issue.SUPPL. 1
, pp. 45-53
-
-
Chung, M.K.1
-
8
-
-
79955933219
-
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the american college of cardiology foundation/american heart association task force on practice guidelines developed in partnership with the european society of cardiology and in collaboration with the european heart rhythm association and the hea
-
10.1016/j.jacc.2010.09.013, 21392637
-
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the american college of cardiology foundation/american heart association task force on practice guidelines developed in partnership with the european society of cardiology and in collaboration with the european heart rhythm association and the heart rhythm society. J Am Coll Cardiol 2011, 57(11):e101-e198. 10.1016/j.jacc.2010.09.013, 21392637.
-
(2011)
J Am Coll Cardiol
, vol.57
, Issue.11
-
-
Fuster, V.1
Ryden, L.E.2
Cannom, D.S.3
Crijns, H.J.4
Curtis, A.B.5
Ellenbogen, K.A.6
Halperin, J.L.7
Kay, G.N.8
Le Huezey, J.Y.9
Lowe, J.E.10
-
9
-
-
79952217693
-
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European society of cardiology guidelines. Part I: primary prevention
-
10.1093/europace/eur002, 21345926
-
Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European society of cardiology guidelines. Part I: primary prevention. Europace 2011, 13(3):308-328. 10.1093/europace/eur002, 21345926.
-
(2011)
Europace
, vol.13
, Issue.3
, pp. 308-328
-
-
Savelieva, I.1
Kakouros, N.2
Kourliouros, A.3
Camm, A.J.4
-
10
-
-
79952217450
-
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European society of cardiology guidelines. Part II: secondary prevention
-
10.1093/europace/eur023, 21515595
-
Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European society of cardiology guidelines. Part II: secondary prevention. Europace 2011, 13(5):610-625. 10.1093/europace/eur023, 21515595.
-
(2011)
Europace
, vol.13
, Issue.5
, pp. 610-625
-
-
Savelieva, I.1
Kakouros, N.2
Kourliouros, A.3
Camm, A.J.4
-
11
-
-
77949492717
-
Role of inflammation and oxidative stress in atrial fibrillation
-
Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D. Role of inflammation and oxidative stress in atrial fibrillation. Hear Rhythm 2010, 7(4):438-444.
-
(2010)
Hear Rhythm
, vol.7
, Issue.4
, pp. 438-444
-
-
Li, J.1
Solus, J.2
Chen, Q.3
Rho, Y.H.4
Milne, G.5
Stein, C.M.6
Darbar, D.7
-
12
-
-
84862269659
-
Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion
-
10.1161/CIRCEP.111.968248, 22362890
-
Ferro D, Franciosa P, Cangemi R, Carnevale R, Pignatelli P, Loffredo L, Perri L, Catasca E, Violi F. Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion. Circ Arrhythm Electrophysiol 2012, 5(2):327-333. 10.1161/CIRCEP.111.968248, 22362890.
-
(2012)
Circ Arrhythm Electrophysiol
, vol.5
, Issue.2
, pp. 327-333
-
-
Ferro, D.1
Franciosa, P.2
Cangemi, R.3
Carnevale, R.4
Pignatelli, P.5
Loffredo, L.6
Perri, L.7
Catasca, E.8
Violi, F.9
-
13
-
-
79961034497
-
Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis
-
10.1160/TH10-10-0660, 21614408
-
Dentali F, Gianni M, Squizzato A, Ageno W, Castiglioni L, Maroni L, Hylek EM, Grandi AM, Cazzani E, Venco A, et al. Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis. Thromb Haemost 2011, 106(2):363-370. 10.1160/TH10-10-0660, 21614408.
-
(2011)
Thromb Haemost
, vol.106
, Issue.2
, pp. 363-370
-
-
Dentali, F.1
Gianni, M.2
Squizzato, A.3
Ageno, W.4
Castiglioni, L.5
Maroni, L.6
Hylek, E.M.7
Grandi, A.M.8
Cazzani, E.9
Venco, A.10
-
14
-
-
79953216728
-
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials
-
10.1136/bmj.d1250, 21411487
-
Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ 2011, 342:d1250. 10.1136/bmj.d1250, 21411487.
-
(2011)
BMJ
, vol.342
-
-
Rahimi, K.1
Emberson, J.2
McGale, P.3
Majoni, W.4
Merhi, A.5
Asselbergs, F.W.6
Krane, V.7
Macfarlane, P.W.8
-
15
-
-
80054947497
-
Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials
-
10.1592/phco.31.11.1051, 22026393
-
Wang Z, Zhang Y, Gao M, Wang J, Wang Q, Wang X, Su L, Hou Y. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Pharmacotherapy 2011, 31(11):1051-1062. 10.1592/phco.31.11.1051, 22026393.
-
(2011)
Pharmacotherapy
, vol.31
, Issue.11
, pp. 1051-1062
-
-
Wang, Z.1
Zhang, Y.2
Gao, M.3
Wang, J.4
Wang, Q.5
Wang, X.6
Su, L.7
Hou, Y.8
-
16
-
-
39149142513
-
Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials
-
10.1016/j.jacc.2007.09.063, 18294568
-
Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008, 51(8):828-835. 10.1016/j.jacc.2007.09.063, 18294568.
-
(2008)
J Am Coll Cardiol
, vol.51
, Issue.8
, pp. 828-835
-
-
Fauchier, L.1
Pierre, B.2
de Labriolle, A.3
Grimard, C.4
Zannad, N.5
Babuty, D.6
-
17
-
-
0029914622
-
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
-
10.1016/0197-2456(95)00134-4, 8721797
-
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17(1):1-12. 10.1016/0197-2456(95)00134-4, 8721797.
-
(1996)
Control Clin Trials
, vol.17
, Issue.1
, pp. 1-12
-
-
Jadad, A.R.1
Moore, R.A.2
Carroll, D.3
Jenkinson, C.4
Reynolds, D.J.5
Gavaghan, D.J.6
McQuay, H.J.7
-
18
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
-
10.1371/journal.pmed.1000097, 2707599, 19621072
-
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072.
-
(2009)
PLoS Med
, vol.6
, Issue.7
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
19
-
-
84959801619
-
Statistical aspects of the analysis of data from retrospective studies of disease
-
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719-748.
-
(1959)
J Natl Cancer Inst
, vol.22
, Issue.4
, pp. 719-748
-
-
Mantel, N.1
Haenszel, W.2
-
20
-
-
1542722283
-
Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion
-
10.1016/j.amjcard.2003.12.009, 15019894
-
Tveit A, Grundtvig M, Gundersen T, Vanberg P, Semb AG, Holt E, Gullestad L. Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 2004, 93(6):780-782. 10.1016/j.amjcard.2003.12.009, 15019894.
-
(2004)
Am J Cardiol
, vol.93
, Issue.6
, pp. 780-782
-
-
Tveit, A.1
Grundtvig, M.2
Gundersen, T.3
Vanberg, P.4
Semb, A.G.5
Holt, E.6
Gullestad, L.7
-
21
-
-
64849083144
-
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study
-
Almroth H, Hoglund N, Boman K, Englund A, Jensen S, Kjellman B, Tornvall P, Rosenqvist M. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. Eur Heart J 2009, 30(7):827-833.
-
(2009)
Eur Heart J
, vol.30
, Issue.7
, pp. 827-833
-
-
Almroth, H.1
Hoglund, N.2
Boman, K.3
Englund, A.4
Jensen, S.5
Kjellman, B.6
Tornvall, P.7
Rosenqvist, M.8
-
22
-
-
33646194460
-
Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion
-
10.1016/j.amjcard.2005.11.082, 16679090
-
Ozaydin M, Varol E, Aslan SM, Kucuktepe Z, Dogan A, Ozturk M, Altinbas A. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol 2006, 97(10):1490-1493. 10.1016/j.amjcard.2005.11.082, 16679090.
-
(2006)
Am J Cardiol
, vol.97
, Issue.10
, pp. 1490-1493
-
-
Ozaydin, M.1
Varol, E.2
Aslan, S.M.3
Kucuktepe, Z.4
Dogan, A.5
Ozturk, M.6
Altinbas, A.7
-
23
-
-
70449705942
-
Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion
-
10.1111/j.1540-8159.2009.02554.x, 19793367
-
Xia W, Yin Z, Li J, Song Y, Qu X. Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion. Pacing Clin Electrophysiol 2009, 32(12):1562-1566. 10.1111/j.1540-8159.2009.02554.x, 19793367.
-
(2009)
Pacing Clin Electrophysiol
, vol.32
, Issue.12
, pp. 1562-1566
-
-
Xia, W.1
Yin, Z.2
Li, J.3
Song, Y.4
Qu, X.5
-
24
-
-
79953328944
-
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)
-
10.1111/j.1540-8167.2010.01925.x, 3022954, 20946227
-
Negi S, Shukrullah I, Veledar E, Bloom HL, Jones DP, Dudley SC. Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial). J Cardiovasc Electrophysiol 2011, 22(4):414-419. 10.1111/j.1540-8167.2010.01925.x, 3022954, 20946227.
-
(2011)
J Cardiovasc Electrophysiol
, vol.22
, Issue.4
, pp. 414-419
-
-
Negi, S.1
Shukrullah, I.2
Veledar, E.3
Bloom, H.L.4
Jones, D.P.5
Dudley, S.C.6
-
25
-
-
79960494933
-
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy
-
10.1159/000327674, 21757938
-
Demir K, Can I, Koc F, Vatankulu MA, Ayhan S, Akilli H, Aribas A, Alihanoglu Y, Altunkeser BB. Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy. Med Princ Pract 2011, 20(5):464-469. 10.1159/000327674, 21757938.
-
(2011)
Med Princ Pract
, vol.20
, Issue.5
, pp. 464-469
-
-
Demir, K.1
Can, I.2
Koc, F.3
Vatankulu, M.A.4
Ayhan, S.5
Akilli, H.6
Aribas, A.7
Alihanoglu, Y.8
Altunkeser, B.B.9
-
26
-
-
0037098199
-
Quantifying heterogeneity in a meta-analysis
-
10.1002/sim.1186, 12111919
-
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558. 10.1002/sim.1186, 12111919.
-
(2002)
Stat Med
, vol.21
, Issue.11
, pp. 1539-1558
-
-
Higgins, J.P.1
Thompson, S.G.2
-
27
-
-
34047154968
-
Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy
-
10.1016/j.pharmthera.2006.12.002, 17287023
-
Tamargo J, Caballero R, Gomez R, Nunez L, Vaquero M, Delpon E. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy. Pharmacol Ther 2007, 114(1):107-126. 10.1016/j.pharmthera.2006.12.002, 17287023.
-
(2007)
Pharmacol Ther
, vol.114
, Issue.1
, pp. 107-126
-
-
Tamargo, J.1
Caballero, R.2
Gomez, R.3
Nunez, L.4
Vaquero, M.5
Delpon, E.6
-
28
-
-
27744531655
-
Effect of C-reactive protein reduction on paroxysmal atrial fibrillation
-
Dernellis J, Panaretou M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J 2005, 150(5):1064.
-
(2005)
Am Heart J
, vol.150
, Issue.5
, pp. 1064
-
-
Dernellis, J.1
Panaretou, M.2
-
29
-
-
34548316779
-
Oxidative stress markers are associated with persistent atrial fibrillation
-
10.1373/clinchem.2006.083923, 3158654, 17599958
-
Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones DP, Dudley SC. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2007, 53(9):1652-1657. 10.1373/clinchem.2006.083923, 3158654, 17599958.
-
(2007)
Clin Chem
, vol.53
, Issue.9
, pp. 1652-1657
-
-
Neuman, R.B.1
Bloom, H.L.2
Shukrullah, I.3
Darrow, L.A.4
Kleinbaum, D.5
Jones, D.P.6
Dudley, S.C.7
-
30
-
-
33745883797
-
NADPH oxidases in cardiovascular health and disease
-
Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006, 8(5-6):691-728.
-
(2006)
Antioxid Redox Signal
, vol.8
, Issue.5-6
, pp. 691-728
-
-
Cave, A.C.1
Brewer, A.C.2
Narayanapanicker, A.3
Ray, R.4
Grieve, D.J.5
Walker, S.6
Shah, A.M.7
-
31
-
-
84857084137
-
Chronic granulomatous disease
-
Loffredo L. Chronic granulomatous disease. Intern Emerg Med 2011, 6(Suppl 1):125-128.
-
(2011)
Intern Emerg Med
, vol.6
, Issue.SUPPL. 1
, pp. 125-128
-
-
Loffredo, L.1
-
32
-
-
26244432775
-
A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
-
10.1161/01.RES.0000183735.09871.61, 16123335
-
Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005, 97(7):629-636. 10.1161/01.RES.0000183735.09871.61, 16123335.
-
(2005)
Circ Res
, vol.97
, Issue.7
, pp. 629-636
-
-
Kim, Y.M.1
Guzik, T.J.2
Zhang, Y.H.3
Zhang, M.H.4
Kattach, H.5
Ratnatunga, C.6
Pillai, R.7
Channon, K.M.8
Casadei, B.9
-
33
-
-
80052602720
-
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins
-
10.1161/CIRCULATIONAHA.111.029223, 21844076
-
Reilly SN, Jayaram R, Nahar K, Antoniades C, Verheule S, Channon KM, Alp NJ, Schotten U, Casadei B. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 2011, 124(10):1107-1117. 10.1161/CIRCULATIONAHA.111.029223, 21844076.
-
(2011)
Circulation
, vol.124
, Issue.10
, pp. 1107-1117
-
-
Reilly, S.N.1
Jayaram, R.2
Nahar, K.3
Antoniades, C.4
Verheule, S.5
Channon, K.M.6
Alp, N.J.7
Schotten, U.8
Casadei, B.9
-
34
-
-
84862869038
-
Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation
-
10.1136/heartjnl-2012-301952, 22628539
-
Cangemi R, Celestini A, Calvieri C, Carnevale R, Pastori D, Nocella C, Vicario T, Pignatelli P, Violi F. Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation. Heart 2012, 98(14):1063-1066. 10.1136/heartjnl-2012-301952, 22628539.
-
(2012)
Heart
, vol.98
, Issue.14
, pp. 1063-1066
-
-
Cangemi, R.1
Celestini, A.2
Calvieri, C.3
Carnevale, R.4
Pastori, D.5
Nocella, C.6
Vicario, T.7
Pignatelli, P.8
Violi, F.9
-
35
-
-
2442708882
-
Should antioxidant status be considered in interventional trials with antioxidants?
-
10.1136/hrt.2003.026930, 1768262, 15145850
-
Violi F, Loffredo L, Musella L, Marcoccia A. Should antioxidant status be considered in interventional trials with antioxidants?. Heart 2004, 90(6):598-602. 10.1136/hrt.2003.026930, 1768262, 15145850.
-
(2004)
Heart
, vol.90
, Issue.6
, pp. 598-602
-
-
Violi, F.1
Loffredo, L.2
Musella, L.3
Marcoccia, A.4
-
36
-
-
84055182538
-
Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment
-
10.1016/j.jacc.2011.08.062, 22192670
-
Antoniades C, Demosthenous M, Reilly S, Margaritis M, Zhang MH, Antonopoulos A, Marinou K, Nahar K, Jayaram R, Tousoulis D, et al. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. J Am Coll Cardiol 2012, 59(1):60-70. 10.1016/j.jacc.2011.08.062, 22192670.
-
(2012)
J Am Coll Cardiol
, vol.59
, Issue.1
, pp. 60-70
-
-
Antoniades, C.1
Demosthenous, M.2
Reilly, S.3
Margaritis, M.4
Zhang, M.H.5
Antonopoulos, A.6
Marinou, K.7
Nahar, K.8
Jayaram, R.9
Tousoulis, D.10
-
37
-
-
38049004028
-
Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E
-
Cangemi R, Loffredo L, Carnevale R, Perri L, Patrizi MP, Sanguigni V, Pignatelli P, Violi F. Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E. Eur Heart J 2008, 29(1):54-62.
-
(2008)
Eur Heart J
, vol.29
, Issue.1
, pp. 54-62
-
-
Cangemi, R.1
Loffredo, L.2
Carnevale, R.3
Perri, L.4
Patrizi, M.P.5
Sanguigni, V.6
Pignatelli, P.7
Violi, F.8
|